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Introduction: The use of immortalized neural stem cells either as models of neural development in vitro or as
cellular therapies in central nervous system (CNS) disorders has been controversial. This controversy has centered
on the capacity of immortalized cells to retain characteristic features of the progenitor cells resident in the tissue of
origin from which they were derived, and the potential for tumorogenicity as a result of immortalization. Here, we
report the generation of conditionally immortalized neural stem cell lines from human fetal spinal cord tissue,
which addresses these issues.
Methods: Clonal neural stem cell lines were derived from 10-week-old human fetal spinal cord and conditionally
immortalized with an inducible form of cMyc. The derived lines were karyotyped, transcriptionally profiled by
microarray, and assessed against a panel of spinal cord progenitor markers with immunocytochemistry. In addition,
the lines were differentiated and assessed for the presence of neuronal fate markers and functional calcium
channels. Finally, a clonal line expressing eGFP was grafted into lesioned rat spinal cord and assessed for survival,
differentiation characteristics, and tumorogenicity.
Results: We demonstrate that these clonal lines (a) retain a clear transcriptional signature of ventral spinal cord
progenitors and a normal karyotype after extensive propagation in vitro, (b) differentiate into relevant ventral
neuronal subtypes with functional T-, L-, N-, and P/Q-type Ca2+ channels and spontaneous calcium oscillations, and
(c) stably engraft into lesioned rat spinal cord without tumorogenicity.
Conclusions: We propose that these cells represent a useful tool both for the in vitro study of differentiation into
ventral spinal cord neuronal subtypes, and for examining the potential of conditionally immortalized neural stem
cells to facilitate functional recovery after spinal cord injury or disease.
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Stem cells have received substantial interest both for
their potential as in vitro tools to study development
and as potential therapeutic agents in a range of dege-
nerative diseases of the nervous system [1]. One area of
particularly strong research activity has been spinal cord
injury (SCI), for which treatment options are very lim-
ited [2]. Stem cells derived from a range of different tis-
sue sources and developmental stages have been studied
for their capacity to elicit functional recovery in animal
models of SCI [3,4]. One such approach has been to
generate immortalized neural stem cell lines from post-
mortem human fetal spinal cord tissue for transplantation
[5-8]. An important question in the use of tissue-specific
immortalized neural stem cell lines as cellular therapies is
the extent to which these cells are able to retain the
phenotypic characteristics of the tissue of origin after
immortalization, prolonged in vitro propagation, and en-
graftment into lesioned tissue.
In the current study, we generated three clonal neural
stem cell lines from human fetal spinal cord, designated
SPC-01, SPC-04, and SPC-06, conditionally immortal-
ized with 4-hydroxy tamoxifen (4-OHT)-inducible cMyc
(cMycERTAM) [9]. This technology involves transducing
primary dissociated cells with a retrovirus containing the
gene cMyc fused to a mutated form of the estrogen re-
ceptor. This fusion protein is specifically activated by the
presence of the synthetic ligand 4-OHT, triggering dime-
rization and translocation to the nucleus. The nuclear
cMycER protein regulates gene expression, and in particu-
lar, directly upregulates telomerase [10], thus allowing the
cell to proliferate indefinitely without undergoing repli-
cative senescence. Removal of 4-OHT from the media
results in inactivation of cMycER and terminal cellular dif-
ferentiation [11].
To assess whether these conditionally immortalized
neural stem cells retain the identity of their tissue of ori-
gin after prolonged in vitro propagation, we performed a
genome-wide transcriptome analysis. This dataset was
then analyzed in terms of the expression of homeodo-
main transcription factors known to play an instructive
role in the identity of progenitor subtypes in the de-
veloping spinal cord [12], and the findings validated by
immunostaining. The ventral spinal cord has four major
interneuron progenitor subdomains (p0, p1, p2, and p3),
and one motoneuron progenitor subdomain (pMN) spe-
cified by the cross-repressive activities of class I and II
homeodomain transcription factors [12]. The ventral
p2 domain of the spinal cord, comprising Nkx6.1+/Irx3+
cells, gives rise to two main lineages of interneurons des-
ignated V2a and V2b, specified by differential Notch sig-
naling [13,14]. A third lineage designated V2c, derived
from the V2b lineage and dependent on Sox1 expression,
has also recently been identified [15]. The genome-widetranscriptome analysis of the conditionally immortalized
neural stem cell lines reported here, and subsequently
confirmed by immunostaining, revealed a homeodomain
transcription-factor profile indicative of the ventral spi-
nal cord p2 and pMN domains.
Furthermore, we demonstrated that on removal of
growth factors and 4-OHT, these cells differentiate into
V2 interneurons and motoneurons, consistent with the
expression of p2 and pMN domain markers in the pro-
genitor cells.
To study the functional properties of neurons derived
from these conditionally immortalized neural stem cells,
we assessed the Ca2+ responses induced by high K+ and
specific Ca2+ channel blockers. Intracellular Ca2+ chan-
ges control many neuronal functions including neuro-
transmitter release [16], membrane excitability [17], gene
transcription [18], and growth [19]. It was shown previ-
ously that, during the period of synaptogenesis, acutely
dissociated embryonic motoneurons express a great va-
riety of voltage-operated Ca2+ channels (VOCCs), able to
induce a Ca2+-induced Ca2+ release (CICR) through a new
type of intracellular Ca2+ pathway functionally linked to
P-type Cav2.1 Ca
2+ channel subunits [20-22]. We found
that neurons derived from the clonal lines described here
express functional T-, L-, N-, and P/Q-type Ca2+ channels.
Furthermore, we demonstrated that a subset of these
neurons exhibit spontaneous calcium oscillations typi-
cally observed in dissociated embryonic rat motoneu-
rons cultures [23].
Finally, in a series of grafting experiments into lesioned
rat spinal cord, we demonstrated that these cells are able
to stably engraft, differentiate into choline acetyltrans-
ferase positive (ChAT+) motoneurons, and show robust
survival after 4 months without tumorogenicity.
Materials and methods
Generation of clonal lines
Ten-week-old fetal tissue was obtained from Advanced
Bioscience Resources (Alameda, CA, USA) after normal
terminations and in accordance with nationally (UK and
USA) approved ethical and legal guidelines [24,25]. Pri-
mary cells were prepared by finely chopping the cervical
region of the fetal spinal cord with a scalpel and disso-
ciation at 37°C with 0.25% trypsin (BioWhittaker) in
DMEM:F12 (Gibco), followed by 0.25 mg/ml soybean
trypsin inhibitor (Gibco). Clonal conditionally immor-
talized cell lines were generated by using MMLV-type
retrovirus encoding the gene cMYC-ERTAM, as previ-
ously described [9,11]. In brief, primary spinal cord cells
transduced with cMYC-ERTAM were plated at clonal den-
sity, and individual colonies were passaged by using glass
cloning cylinders (Sigma-Aldrich). Spinal cord clones
SPC-01, SPC-04, and SPC-06 were initially selected based
on uniform growth over 20 population doublings before
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line 1 (SPC-01) expressing eGFP was also generated by
using a lentiviral vector containing a ubiquitous chromatin
opening element to prevent silencing on engraftment, as
previously described [26].
Cell growth and differentiation
Cell lines were routinely cultured, as previously de-
scribed in Pollock et al. [11]. In brief, cells were grown
on laminin-coated (Sigma-Aldrich), tissue-culture flasks
in DMEM/F12 supplemented with bFGF (10 ng/ml),
EGF (20 ng/ml) (PeproTech, UK); human serum albu-
min (0.03%) (Baxter Healthcare); L-glutamine (2 mM)
(Gibco); human transferrin (100 μg/ml), putrescine di-
hydrochloride (16.2 μg/ml), human insulin (5 μg/ml),
progesterone (60 ng/ml), sodium selenite (selenium)
(40 ng/ml), and 4-OHT (100 nM) (Sigma-Aldrich). Cell
differentiation was triggered by the removal of growth
factors and 4-OHT from the media with or without the
addition of N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT) (10 μM) or all-trans
retinoic acid (ATRA), as indicated in the text. Long-
term growth and population doublings were monitored
by recording the total number of cells at each passage.
Karyotyping analyses
Cells at 70% to 80% confluence were treated with 100
ng/ml colcemid (Life Technologies), for 3 hours, and
subjected to hypotonic lysis in 0.075 M potassium chlo-
ride for 10 minutes at 37°C. Samples were then fixed in
methanol/glacial acetic acid (ratio 3:1) and stained with
Giemsa on glass slides for analysis.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 15 minutes
at room temperature, washed with PBS, and permeabi-
lized with 0.1% Triton-X100/tris-buffered saline (TBS)
for 30 minutes. Nonspecific binding was then blocked
with 10% normal donkey serum in TBS for 1 hour at
room temperature. Cells were then probed with primary
antibodies to Nestin (1:500; Chemicon), Sox2, and ChAT
(1:1,000; Millipore), βIII tubulin and Irx3 (1:1,000;
Sigma-Aldrich), Tau and S100Β (1:2,000; DAKO), Olig2,
and MASH1 (1:200; Millipore), Pax6, Nkx6.1, Lhx3, En1,
and Isl1 (all Developmental Studies Hybridoma Bank
(University of Iowa), 1:200), and Chx10 and GATA3
(1:250; Abcam) at 4°C overnight. Secondary antibodies
used were donkey anti-mouse Alexa 488, donkey anti-
rabbit Alexa 594, donkey anti-sheep Alexa 488, donkey
anti-goat Alexa 488, and donkey anti-rabbit Alexa 680
(all 1:300, Molecular Probes), as appropriate, in 1%
NDS/TBS for 1 hour at room temperature. Cells were
then washed with TBS and counterstained with 1 μM
Hoechst 33342 (Sigma-Aldrich).Cell counting
All cell counting was carried out in biologic triplicate, in
which the experiment was replicated with cells plated
several passages apart. Each biologic replicate consisted
of three wells (technical replicates) for each condition.
Each technical replicate consisted of three randomly
placed nonoverlapping images taken per well with the
40× objective. Images were imported into ImageJ, and
nuclei and target-positive cells were counted manually.
The three-well images were averaged to generate one
technical replicate. The three technical replicates (wells)
were averaged to generate one biologic replicate (plate),
which was then used for statistical analysis. All cell
counting was carried out from images taken from the
1×70 inverted microscope (Olympus) and processed
with the Axio Vision Digital Image Processing Software
(Carl Zeiss Inc.). Exposure times were kept consistent
for each target. Differences in the proportion of marker-
positive cells between cell lines were tested for statis-
tical significance by using a one-way ANOVA for each
marker (Prism).
Microarray analysis
RNA was extracted from cultured cells by using Trizol
(Life Technologies), and DNase treated with Turbo
DNase (Life Technologies). RNA was assessed for quality
with an Agilent Bioanalyzer ensuring an RNA integrity
number greater than 9. Genome-wide gene-expression
profiling was performed with the Illumina HumanWG-6
v3.0 expression beadchip array, at the Welcome Trust
Centre for Human Genetics (Oxford, UK). Sample probe
profiles were exported from GenomeStudio into lumi
(bioconductor). Variance-stabilizing transformation was
applied to datasets, quantile normalized, and log2 trans-
formed. All microarray data from this study are available
through the Gene Expression Omnibus [27], with acces-
sion number GSE37282.
Drugs and solutions
Unless otherwise stated, all standard chemicals were ob-
tained from Sigma-Aldrich (St. Louis, MO, USA). San-
dimmune (Novartis Pharma AG, Basel, Switzerland);
Immuran (GlaxoSmith-Kline); Solu-Medrol (Pfizer, Puurs,
Belgium); Fura-2 AM 1 mM solution in anhydrous DMSO
and Pluronic F-127 (30% stock in distilled water) (Mole-
cular Probes, USA); ω-Aga Toxin IVA (ω-Aga IVA),
and ω-conotoxin GVIA (ω-GVIA) (Alomone Labs Ltd.
Jerusalem, Israel). Concentrated stock solutions of nicardi-
pine were prepared in DMSO, whereas the remaining
stock solutions of Ca2+-channel toxins were dissolved in
dH2O. All concentrated stock solutions were stored
at −20°C. Test solutions were prepared daily by using
aliquots from frozen stocks to obtain the working
concentrations. All buffers and solutions used for the
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free dH2O from Merck-Germany.
Solutions for [Ca2+]i measurements
Normal Locke (NL) buffer was used for [Ca2+]i measure-
ments on single cells in culture, containing (mM): NaCl,
140; KCl, 5; MgCl2, 1.2; CaCl2, 2.2; glucose, 10; HEPES-
Tris, 10; BSA, 0.02%; pH 7.25. The osmolarity of the so-
lutions used ranged between 298 and 300 mosmol/l-1.
High-K+ buffer contained (mM): NaCl, 90; KCl, 50;
MgCl2, 1.2; CaCl2, 2.2; glucose, 10; HEPES, 10; at pH
7.25. For other K+ concentrations, KCl was added at
the desired concentration and was adjusted with NaClFigure 1 Characterization of human spinal cord neural stem cells con
expresses the neural stem cell markers Nestin and Sox2. (b) Cytogenetic an
cells), revealed a 46,XX normal female karyotype, demonstrating that condi
affect chromosomal stability in this line.appropriately to bring the osmolarity to the required
range. The Ca2+-channel blockers ω-GVIA and ω-Aga
IVA were prepared as concentrated stocks in distilled
water, stored at −70°C, and diluted to working con-
centrations before use. The control and test solutions
were applied by using a multiple capillary perfusion sys-
tem (200 μm inner-diameter capillary tubing; flow rate,
250 μl/min), and the cells were subjected to a constant
fast-flow control buffer. Each capillary was fed by a reser-
voir 30 cm above the bath and connected to a tempera-
ture-control device (Harvard-France). In this approach,
switching the flow from one capillary to the next resulted
in complete solution changes within 2 to 5 seconds. Afterditionally immortalized with cMycER. (a) Clonal line SPC-01
alysis of SPC-01 after 60 population doublings (n = 20 metaphase
tional immortalization with cMycER and prolonged culture did not
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with control buffer. This method allowed fast and reliable
exchange of the solution surrounding the cells.
[Ca2+]i measurements on individual SPC-01-derived
neurons
Intracellular calcium ([Ca2+]i) measurements on single
cells were performed after 10 days of differentiation by
using fast fluorescence spectrofluorimetry. SPC-01 cells
differentiated on 22-mm glass-bottom dishes (WillCo
Wells BV) were incubated with 2.5 μM Fura-2 AM plus
0.02% Pluronic F-127 at 24°C for 50 minutes. The prepa-
rations were then washed with dye-free solution and
kept at 37°C until used. Fluorescence measurements
of [Ca2+]i were performed with the Zeiss Microscope
Photometer System (Fast Fluorescence Photometer
(FFP), Zeiss, Germany), based on an inverted micro-
scope (Axiovert; Zeiss) equipped for epifluorescence
(objective, Plan-Neofluar 100 ×/1.30 oil immersion).
The cells were alternately illuminated (200 Hz) at 340 ± 10
and 380 ± 10 nm. To minimize the background noise of
the Fura-2 signal, successive values were averaged to a
final time resolution of 308 milliseconds. For fast swit-
ching between different excitation wavelengths, a rotating
filter wheel was mounted in the excitation light path. A
measuring amplifier was synchronized to the filter wheel
to measure the fluorescence intensities resulting from
different wavelengths. The FFP software controlled theTable 1 Log2-transformed data from Illumina beadchip expre
Log2 exp
Region Gene ID SPC-01
Roof plate LMX1A 5.55 (0.48
GDF7 5.94 (0.90














Floor plate FOXA2 4.40 (0.09
Expression of a subset of dorsal and ventral spinal cord markers is shown along wit
detection above background noise (P < 0.05).acquisition of intensity data and provided functions for
adjusting the signal values, the display and storage of the
measured data, and calculations of ion concentrations. A
CCD camera was used to visualize the cells. With fluores-
cence values corrected for background and dark current,
[Ca2+]i calculations were carried out from the ratio be-
tween 340- and 380-nm recordings. Fura-2 calibration
was performed with the actual instrument by following
the same procedure described previously [28], which
yielded Rmin = 0.16; Rmax = 3.173; β = 2.968; and Kd = 224
at 37°C.
Statistics
Origin 8.5.1 was used for plotting and statistical proce-
dures (OriginLab). The results are expressed as mean ±
SEM. The number of the sample size (n) given is the
number of cells tested according to the same protocol
(control, test drug, recovery) for each group. The figures
(traces) show on-line single-cell measurements of the
[Ca2+]i levels before and after the application of test sub-
stances, whereas bar diagrams and numeric data are
given as mean ± SEM and present the peak amplitude of
the [Ca2+]i increase as concentration (in nM) calculated
fluorescence values of 340/380 nm excitation wavelengths.
The results were analyzed by using one-way ANOVA.
Differences were considered statistically significant if
P ≤ 0.05.ssion analysis of SPC-01, SPC-04, and SPC-06 cell lines
ression values (detection P value)
SPC-04 SPC-06
) 4.80 (0.30) 4.16 (0.05)
) 5.80 (0.89) 5.56 (0.75)
) 5.85 (0.81) 6.08 (0.91)
) 6.34 (0.96) 6.06 (0.91)
) 5.09 (0.18) 5.37 (0.73)
) 5.18 (0.37) 5.40 (0.46)
) 5.00 (0.15) 5.31 (0.34)
0) 9.02 (1.00) 9.27 (1.00)
) 4.84 (0.37) 6.17 (0.94)
00) 11.50 (1.00) 14.12 (1.00)
) 4.86 (0.26) 5.85 (0.85)
8) 7.29 (0.99*) 7.05 (0.99)
00) 13.77 (1.00) 14.63 (1.00)
5) 8.25 (1.00) 6.28 (0.93)
00) 10.11 (1.00) 10.33 (1.00)
) 5.53 (0.63) 5.20 (0.30)
) 4.80 (0.07) 4.37 (0.02)
h detection P values. Detection P values shown in bold represent significant
Figure 2 Immunocytochemistry for ventral spinal cord markers. (a through c) Undifferentiated SPC-01 cells express the homeodomain
transcription factors IRX3, PAX6, and NKX6.1, indicative of the p2 domain of the developing ventral spinal cord. (d) A low level of OLIG2 can also
be detected in these cells, suggesting a slightly broader developmental potential also encompassing the adjacent pMN domain.
Figure 3 Characterization of SPC-01 differentiation. Differentiation of SPC-01 by removal of growth factors and 4-OHT for 7 days gives rise to
tau+ neurons (left panel). Consistent with the homeodomain transcription-factor profile observed in the undifferentiated cells, a subset of these
tau+ neurons coexpress LHX3 and CHX10, indicative of V2a interneurons (middle panel). However, a subpopulation of NKX6.1+/CHX10- neurons
can also be observed (right panel, white arrows).
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Figure 4 (See legend on next page.)
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Figure 4 Notch inhibition regulates the fate of SPC-01. (a) Treatment of undifferentiated SPC-01 with the γ-secretase inhibitor DAPT (10 μM)
for 48 hours upregulates MASH1 expression in SPC-01. (b, c) On differentiation, cultures of SPC-01 pretreated with DAPT for 48 hours gave rise to
a significantly greater proportion of neurons with a CHX10+ V2a interneuronal phenotype (P < 0.01, means ± SEM, n = 3). This suggests that
differential Notch signaling in the undifferentiated SPC-01 cells is giving rise to subpopulations of ventral interneurons, which can be directed
into a V2a interneuronal fate by inhibition of Notch.
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All animal experiments were approved by the Animal
Committee of the Czech Republic and the Animal Care
and Use of Animals Committee of the Institute of
Experimental Medicine AS CR. Adult male Wistar rats
weighing 280 to 300 g were anesthetized with isofluo-
rane vapor inhalation (3% to 5%), and a balloon-induced
spinal cord compression lesion was performed at the
Th8 to Th9 level of the spinal cord, according to pro-
tocols previously described [29]. The animals were assis-
ted with manual urination twice a day until the reflex
returned, and gentamicin was administered by intramus-
cular injection twice a day for 3 days. Cell transplan-
tation was performed 7 days after SCI, according to a
previously published procedure [30]. For transplantation,
SPC-01 cells were detached by TrypZean (Lonza).
Harvested cells were grafted by using a stereotaxic injec-
tion instrument (Stoelting Co., Wood Dale, IL, USA)
and a nanoinjector pump (KD Scientific Inc, Hillstone,
MA, USA). In total, of 5 × 105 cells suspended in 5-μl
growth media were injected into the epicenter of the le-
sion, at a depth of 2 mm. All grafted rats (n = 22) were
immunosuppressed with Sandimmun (Novartis Pharama
AG, Basel, Switzerland; 10 mg/kg intraperitoneally),
Immuran (GlaxoSmith-Kline, 4 mg/kg intraperitoneally),
and Solu-Medrol (Pfizer, Puurs, Belgium; 2 mg/kg intra-
muscularly) 24 hours before transplantation and then
daily until the end of the experiment.
Histology and immunohistochemistry
The animals were killed and perfused either 8 weeks
(n = 16) or 4 months (n = 6) after cell transplantation for
histologic examination. The rats were deeply anesthe-
tized, and 200 ml of PBS was perfused intracardially into
the left ventricle, followed by 300 ml of ice-cold 4%
(vol/vol) PFA in 0.1 M PBS. The spinal cords were dis-
sected, immersed in 4% (vol/vol) PFA at 4°C for 24
hours, and then placed in 30% (wt/vol) sucrose for 3
days. After freezing, spinal cords were cryosectioned
longitudinally in 14-mm-thick slices. To identify SPC-01
cells transplanted into the rat spinal cord, antibodies di-
rected against human mitochondria (MTCO2; mouse
monoclonal, 1:125, Abcam), human nuclei (HuNu; mouse
monoclonal 1:40, Millipore), choline acetyltransferase
ChAT (rabbit polyclonal, 1:100, Abcam), nestin (rabbit
polyclonal, 1:200 Millipore), Islet2, Nkx 6.1 (both mousemonoclonal, 1:20, Developmental Studies Hybridoma
Bank), and GFAP (mouse monoclonal 1:200, Sigma-
Aldrich) were used. The Ki67 index and the number
of Nkx 6.1-positive cells were calculated as the ratio
of Ki67/HuNu-positive cells or Nkx 6.1/HuNu-posi-
tive cells to the total number of HuNu-positive cells.
Results and discussion
cMycER conditionally immortalized spinal cord neural
stem cells retain a normal karyotype and regional identity
after prolonged culture
Three conditionally immortalized clonal lines demon-
strating robust growth were characterized and desig-
nated spinal cord lines 01, 04, and 06 (SPC-01, SPC-04,
and SPC-06). An initial characterization demonstrated
that under proliferating conditions, these lines expressed
the generic neural stem cell markers NESTIN and SOX2
(Figure 1a and Additional file 1: Figure S1). To examine
whether cMyc conditional immortalization and prolon-
ged passage affected genomic integrity, we performed
chromosomal analysis on SPC-01 after 60 population
doublings. This revealed a 46,XX normal female karyo-
type in 20 cells analyzed (Figure 1b), demonstrating that
these cell lines are karyotypically stable.
To assess whether the spinal cord lines had retained
regional identity, we performed transcriptional profiling
by microarray. We identified a subset of homeodomain
transcription factors, NKX6.1, NKX6.2, IRX3, and PAX6,
to be highly expressed (Table 1), indicative of the de-
veloping spinal cord p2 domain [12]. The expression of
NKX6.1, IRX3, and PAX6 was confirmed by immuno-
staining (Figure 2a through c). Expression of the ventral
spinal cord transcription factors DBX1, DBX2, NKX2.2,
and FOXA2, corresponding to the p0, p1, p3, and floor-
plate domains, respectively, was below the threshold of
detection (Table 1). However, a low level of expression
of OLIG2, corresponding to the ventral spinal cord
pMN domain, was also observed and confirmed with
immunocytochemistry (Figure 2d). The expression of
transcription factors corresponding to the roofplate and
dorsal spinal cord subdomains LMX1A, GDF7, ATOH1,
OLIG3, GSX1, GSX2, and PTF1A were all below the
threshold of detection (Table 1). As all three lines had a
broadly similar profile of transcription factor expression,
we focused all subsequent analysis on SPC-01.
Figure 5 SPC-01 generates functional neurons. (a) Preincubation with Cd2+ (100 μM) together with Ni2+ (50 μM), for 5 minutes significantly
reduced the [Ca2+]i responses induced by K
+ in all cells tested by 93% ± 9.2% (n = 5), indicating the involvement of voltage-activated Ca2+
channels in depolarization-induced Ca2+ entry. (b) The specific L-type Ca2+ channel blocker nicardipine (1 μM) reduced the [Ca2+]i responses by
28% ± 7% (n = 5; P = 0.002). The trace in (c) shows the [Ca2+]i responses observed in a selected SPC-01-derived neuron induced by 50 mM K
+,
preincubated for 2 minutes with Ω -GVIA (800 nM) and then stimulated with K+. After a washout of 10 minutes, the same cells were subjected to
K+ to observe recovery. Similarly, the effect of the P/Q-Ca2+ channel blocker, Ω -Aga-IVA, 300 nM was tested before and during stimulation with
high K+ (d). After washout of the toxin, the [Ca2+]i response was shown to be reversible. The histogram (e) summarizes the results presented in
(c) and (d). The resting [Ca2+]i level in these cells is indicated as basal. The results are expressed as mean ± SEM; n = 4 (Ω-GVIA) and n = 5
(Ω-Aga-IVA). Asterisks indicate the statistical significance (P > 0.05) versus control K+ stimulus.
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Figure 6 Differentiated SPC-01 displays spontaneous calcium
oscillations. SPC-01 cells were analyzed in the NL buffer for
spontaneous oscillations in [Ca2+]i in the presence (Trace A: three
examples) or absence of 2 mM external Ca2+ (Trace B). Note that the
Ca2+ oscillations were abolished in the absence of external Ca2+.
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The expression of ventral spinal cord p2 domain tran-
scription factors in the SPC lines suggests that these
lines should give rise to V2 interneurons [31]. After the
removal of growth factors and 4-OHT for 7 days, SPC-
01 differentiates into a mixed population of mainly neu-
rons and astrocytes (10% and 79%, respectively) with
very small numbers of oligodendrocytes (<1%) (Additional
file 2: Figure S2). As expected, the majority of neurons
generated have an LHX3/CHX10/TAU+ fate, indicative of
spinal V2a interneurons (Figure 3). Although a majority
of neurons generated by SPC-01 after the withdrawal of
growth factors and 4-OHT were CHX10+, a subset of
CHX10-ve/TAU+ neurons was found (Figure 3, right
panel, and Figure 4b, white arrows). In addition, these
CHX10-/TAU+ neurons were also EN1-, GATA3-, and
ISL1- (Figure 4c), suggesting that they are not V1 or
V2b interneurons or motoneurons [31,32]. A recent publi-
cation indicated the existence of a third V2 interneuronal
subtype termed V2c, generated from V2b Gata3+ proge-
nitors [15]. On differentiation, these V2c interneurons
upregulate Sox1 while downregulating Gata3. Future work
will seek to determine whether these CHX10-/Tau+ neu-
rons are V2c interneurons.
Differential Notch signaling has been demonstrated to
specify the binary-fate decision of p2 progenitors be-
tween V2a excitatory and V2b inhibitory interneurons
[13,14]. We therefore speculated that inhibition of Notch
should drive a V2a excitatory fate in these clonal lines.
Inhibition of Notch for 48 hours by the γ-secretase in-
hibitor DAPT upregulated Mash1 in undifferentiated
SPC-01 (Figure 4a) and, on differentiation, resulted in a
significant increase in the proportion of Chx10+ neurons
(Figure 4b and 4c). Notch inhibition therefore drives a
V2a interneuronal fate in these cells. Significant progress
has been made in identifying the components and stoi-
chiometric interactions of the transcription factor com-
plexes involved in specifying the fate of p2 progenitors
into these different interneuron subtypes [33,34]. The
ability of SPC-01 to rapidly and reproducibly differenti-
ate into V2a Chx10+ interneurons represents a useful
tool to study the acquisition of V2 interneuronal fates
in vitro.
Given that SPC-01 also expresses low levels of OLIG2,
a marker of the pMN domain, we asked if these cells
were also competent to give rise to motoneurons. It was
shown previously that retinoid signaling is required for
the specification of motoneuron fate in the ventral spinal
cord [35]. We therefore sought to drive the fate of SPC-
01 cells along a motoneuron lineage by the addition of
100 nM ATRA for the first 2 days of differentiation. We
found that SPC-01 did indeed give rise to ISL1+ putative
motoneurons (Additional file 3: Figure S3a). However,
these Isl1+ neurons represent only a small subpopulation(<5%) of the total neurons generated (Additional file 3:
Figure S3b), suggesting that the default differentiation of
these cells is toward a V2 interneuronal fate.
[Ca2+]i responses in SPC-01-derived neurons
It was previously shown that Ca2+ entering the cytosol
via voltage-operated Ca2+ channels (VOCCs) regulates
many processes in neurons, including the initiation of
synaptic transmission [17], gene expression [18], and
growth-cone behavior [19]. Although L- and T-type Ca2+
currents are found in a wide range of cells, N-, P-, Q-, and
R-type Ca2+ currents are most prominent in neurons. In
purified embryonic rat motoneuron preparations, it has
been shown by using the patch-clamp technique that
these cells express T-, L-, N-, and P/Q-type Ca2+ channels
[23]. In the current study, [Ca2+]i measurements revealed
that SPC-01-derived neurons also express functional T-,
L-, N-, and P/Q-type Ca2+ channels. Under resting condi-
tions, the basal (resting) [Ca2+]i levels in these neurons va-
ried, depending on the day of culture, from 101 ± 12 nM
at 3 days after plating (n = 33) to 113 ± 17 nM on the fifth
day (n = 28). These insignificant variations of the resting
[Ca2+]i did not appear to have any physiological rele-
vance. Therefore, [Ca2+]i measurements were performed
Cocks et al. Stem Cell Research & Therapy 2013, 4:69 Page 11 of 13
http://stemcellres.com/content/4/3/69on cultures between 3 and 7 days old. After establishing
their resting [Ca2+]i levels, we determined the functional
aspects of SPC-01-derived neurons in culture by evaluat-
ing their [Ca2+]i responses to high K
+ (50 mM KCl). Only
morphologically distinct neuronal-like cells were taken
into consideration. We monitored Ca2+ entry through
VOCCs as [Ca2+]i transients evoked by depolarization
with 50 mM K+. The application of high-K+ solution
evoked a rapid increase in [Ca2+]i in 50% (n = 56) of the
tested cells in three different cultures. Preincubation with
Cd2+ (100 μM), a nonspecific blocker of high-voltage acti-
vated (HVA) Ca2+ channels (L-, N-, P-, Q-, and R-types),
together with Ni2+ (50 μM), a more-specific blocker
of low-voltage activated (LVA) Ca2+ channels (T-type),
for about 5 minutes significantly reduced the [Ca2+]i
responses induced by K+ in all cells tested by 93% ± 9.2%
(n = 5), indicating the involvement of voltage-activated
Ca2+ channels in depolarization-induced Ca2+ entry
(Figure 5a). Further to characterize the involvement
of specific subtypes of HVA Ca2+ channels, we used
specific Ca2+ channel blockers, such as nicardipine (for
L-type), ω-conotoxin GVIA (for N-type), and ω-Aga toxin
IVA (for P/Q- type). The application of 1 μM nicardipineFigure 7 Engraftment of SPC-01 in lesioned rat spinal cord. (a) Surviva
lesioned rat spinal cord. Two months after transplantation, the majority of
also coexpressed GFAP (arrows) (c). Approximately 20% of the grafted cells
nestin expression was condensed into long fibers (e), and a subpopulationreduced [Ca2+]i responses by 28% ± 7% (n = 5; P = 0.002;
Figure 5b), suggesting the contribution of L-type Ca2+
channels in SPC-01 neurons. The application of a spe-
cific N-type blocker, ω-conotoxin GVIA, at 800 nM ω-
conotoxin (Figure 5c), reduced the [Ca2+]i responses by
42% ± 11% (P = 0.001; n = 7) in all neurons.
In another set of experiments, we tested the [Ca2+]i re-
sponses induced by high K+ in the presence of the spe-
cific P/Q-type Ca2+ channel blocker Ω-Aga-IVA. The P/
Q-type Ca2+ channel is typically expressed in rat embry-
onic and adult motoneurons [23]. Ω-Aga-IVA (300 nM)
was found significantly to block the [Ca2+]i responses
induced by high K+ by 76% ± 24% (n = 9; P = 0.001;
Figure 5d), suggesting the importance of functional P/
Q-type Ca2+ channels in SPC-01 neurons. These re-
sults suggest the expression of T, L-, N- and P/Q-type
Ca2+ channels in motoneuron-like cells in differentia-
ted SPC-01.
Spontaneous [Ca2+]i activity is an essential feature of
developing neurons [36]. In the present investigation, we
also observed that SPC-01 neurons exhibited spontan-
eous oscillations in [Ca2+]i, suggesting the existence of a
calcium-induced calcium-release mechanism through thel of SPC-01_eGFP was observed 4 months after engraftment into
SPC-01 cells remained nestin-positive (b), and a subpopulation of these
expressed NKX6.1 (arrows) (d). Four months after transplantation,
of cells expressed the motoneuron markers ISL2 (f) and ChAT (g).
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neurons exhibited spontaneous [Ca2+]i oscillations under
resting conditions (Figure 6a), typically observed in mo-
toneurons from E14 rat cultures [23]. The amplitude of
the spontaneous [Ca2+]i transients was 296 ± 19, and they
appeared with a mean frequency of 1 per 37 ± 6 seconds.
These transients were totally abolished by the removal of
external Ca2+ in all seven tested neurons (Figure 6b). To-
gether, these data provide evidence that SPC-01 generates
functional neurons that express multiple Ca2+ channels
and spontaneous activity characteristic of motoneurons.SPC-01 stably engrafts in the lesioned rat spinal cord
without tumorogenicity
The cMycERTAM conditional immortalization techno-
logy has been used to generate neural stem cell lines
from different regions of the CNS as potential cellular
therapies for conditions including stroke and Parkinson
disease [11,37,38]. A cMycERTAM conditionally immor-
talized human cortical cell line is currently being eval-
uated in a phase I clinical trial for stroke [39]. We have
assessed the capacity of SPC-01 transduced with eGFP
to both survive engraftment in the lesioned rat spinal
cord and differentiate into appropriate neuronal sub-
types without tumorogenicity. Robust engraftment of
SPC-01_eGFP was observed 4 months after engraftment
(Figure 7a). In all cases, cells filled the lesion cavity and
did not migrate far from the lesion. Two months af-
ter transplantation, the majority of SPC-01 cells were
nestin-positive (Figure 7b), a subpopulation of which
also coexpressed GFAP (Figure 7c; see Additional file 4:
Figure S4a). Approximately 20% of the grafted cells ex-
pressed NKX6.1 (Figure 7d; Additional file 4: Figure S4b).
Four months after transplantation, nestin expression was
confined to individual fibers (Figure 7e; Additional file 4:
Figure S4c), and we observed the expression of the moto-
neuron markers ISL2 (Figure 7f; Additional file 4: Figure
S4d) and ChAT (Figure 7g; Additional file 4: Figure S4e)
in a subpopulation of cells. The Ki67 proliferation index
of in vivo grafted cells ranged from 1.5% to 5.3%, and no
tumor formation or hyperproliferative activity was ob-
served during the whole in vivo period.Conclusions
We generated immortalized neural stem cell lines from
human fetal spinal cord; these retain the phenotypic
characteristics of the tissue of origin even after prolonged
in vitro propagation and engraftment into lesioned ro-
dent spinal cord. These cell lines therefore represent
a useful tool for studying V2 interneuron differentia-
tion in vitro and for further examining the potential
of human neural stem cells as cellular therapies for
spinal cord injury.Additional files
Additional file 1: Figure S1. Clonal lines SPC-04 (A) and SPC-06 (B)
express the neural stem cell markers Nestin and Sox2.
Additional file 2: Figure S2. The percentage of tau+ neurons, GFAP+
astrocytes, and O4+ oligodendrocytes 7 days after removal of growth
factors and 4-OHT (mean ± SEM, n = 3) in clonal line SPC-01.
Additional file 3: Figure S3. (A) Treatment of SPC-01 with ATRA
(100 nM) for the first 48 hours of a 14-day differentiation protocol gave
rise to small numbers of Isl1+ putative motoneurons. (B) The percentage
of tau+ neurons expressing the ventral interneuron fate markers En1,
Chx10, GATA3, and the motoneuron marker Isl1 after 48 hours of
treatment with ATRA (100 nM) and a further 5 days of differentiation
without growth factors or 4-OHT (means ± SEM, n = 3).
Additional file 4: Figure S4. Orthographic projections of engrafted
cells where Additional file 4: Figures S4A to S4E correspond to Figure 7C
to G, respectively.Abbreviations
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